Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Adient
ADNT
$1.44B
| $11.2M | 0.02% |
744,935
+553,551
| +289% | +$14.3M |
|
1052
Unisys
UIS
$196M
| $11.2M | 0.02% |
964,666
-708,330
| -42% | -$11.1M |
|
1053
iShares MSCI Emerging Markets ETF
EEM
$31.3B
| $11.2M | 0.02% |
286,804
+4,890
| +2% | +$196K |
|
|
BFYT
1054
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $11.2M | 0.02% |
+418,895
| New | +$16.8M |
|
1055
Sabesp
SBS
$16.9B
| $11.2M | 0.02% |
7,150,039
+1,019,614
| +17% | +$1.47M |
|
1056
Littelfuse
LFUS
$10.3B
| $11.2M | 0.02% |
65,228
-47,816
| -42% | -$8.53M |
|
|
STEL
1057
DELISTED
Stellar Bancorp
STEL
| $11.2M | 0.02% |
380,016
+62,004
| +19% | +$2.06M |
|
1058
Hancock Whitney
HWC
$5.99B
| $11.2M | 0.02% |
322,128
-65,046
| -17% | -$2.63M |
|
1059
Morningstar
MORN
$8.07B
| $11.1M | 0.02% |
101,398
+56,052
| +124% | +$6.57M |
|
1060
Urban Edge Properties
UE
$2.74B
| $11.1M | 0.02% |
669,480
+294,346
| +78% | +$5.8M |
|
1061
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.1B
| $11.1M | 0.02% |
98,454
-71,951
| -42% | -$8.09M |
|
1062
Open Text
OTEX
$5.9B
| $11.1M | 0.02% |
340,734
+27,919
| +9% | +$943K |
|
1063
Chemours
CC
$2.37B
| $11.1M | 0.02% |
393,488
-486,414
| -55% | -$15.4M |
|
1064
Ralph Lauren
RL
$21.6B
| $11.1M | 0.02% |
107,223
-448,191
| -81% | -$52.8M |
|
1065
Mondelez International
MDLZ
$80.4B
| $11.1M | 0.02% |
276,977
+234,539
| +553% | +$10M |
|
1066
iShares MSCI India ETF
INDA
$6.7B
| $11.1M | 0.02% |
332,389
+196,182
| +144% | +$6.18M |
|
|
CRZO
1067
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $11.1M | 0.02% |
979,016
-254,403
| -21% | -$4.53M |
|
|
ARQL
1068
DELISTED
Arqule Inc
ARQL
| $11M | 0.02% |
3,981,553
-2,376,004
| -37% | -$9.07M |
|
1069
Repligen
RGEN
$10.3B
| $11M | 0.02% |
+208,976
| New | +$12.3M |
|
1070
Lithia Motors
LAD
$8.18B
| $11M | 0.02% |
144,024
+18,645
| +15% | +$1.47M |
|
1071
ACI Worldwide
ACIW
$5.29B
| $11M | 0.02% |
396,898
+74,560
| +23% | +$2.02M |
|
|
GBT
1072
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11M | 0.02% |
267,341
+138,413
| +107% | +$5.19M |
|
1073
ExxonMobil
XOM
$661B
| $11M | 0.02% |
160,849
+118,595
| +281% | +$9.3M |
|
1074
Brink's
BCO
$4.57B
| $10.9M | 0.02% |
169,310
+44,456
| +36% | +$2.93M |
|
1075
Mueller Water Products
MWA
$3.89B
| $10.9M | 0.02% |
1,201,647
+241,713
| +25% | +$2.53M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.